ATE440868T1 - Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen - Google Patents

Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen

Info

Publication number
ATE440868T1
ATE440868T1 AT98910699T AT98910699T ATE440868T1 AT E440868 T1 ATE440868 T1 AT E440868T1 AT 98910699 T AT98910699 T AT 98910699T AT 98910699 T AT98910699 T AT 98910699T AT E440868 T1 ATE440868 T1 AT E440868T1
Authority
AT
Austria
Prior art keywords
prion protein
monoclonal antibodies
antibodies against
detecting prions
antibody
Prior art date
Application number
AT98910699T
Other languages
English (en)
Inventor
Carsten Korth
Beat Stierli
Peter Streit
Bruno Oesch
Markus Moser
Original Assignee
Universitaet Zurich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Zurich filed Critical Universitaet Zurich
Application granted granted Critical
Publication of ATE440868T1 publication Critical patent/ATE440868T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2872—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against prion molecules, e.g. CD230
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98910699T 1997-02-21 1998-02-18 Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen ATE440868T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97102837A EP0861900A1 (de) 1997-02-21 1997-02-21 Immunologischer Nachweis von Prionen
PCT/EP1998/000917 WO1998037210A1 (en) 1997-02-21 1998-02-18 Immunological detection of prions

Publications (1)

Publication Number Publication Date
ATE440868T1 true ATE440868T1 (de) 2009-09-15

Family

ID=8226511

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98910699T ATE440868T1 (de) 1997-02-21 1998-02-18 Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen

Country Status (8)

Country Link
US (2) US6765088B1 (de)
EP (3) EP0861900A1 (de)
AT (1) ATE440868T1 (de)
AU (1) AU742838B2 (de)
CA (1) CA2280791C (de)
DE (1) DE69841102D1 (de)
NZ (1) NZ336656A (de)
WO (1) WO1998037210A1 (de)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221614B1 (en) 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
US6617119B2 (en) 1997-02-21 2003-09-09 The Regents Of The University Of California Assay for specific strains of multiple disease related conformations of a protein
US6620629B1 (en) 1997-02-21 2003-09-16 The Regents Of The University Of California Method for detecting prions
DE19741607A1 (de) * 1997-09-20 1999-03-25 Prionics Ag Synthetische Polypeptide zur Diagnose und Therapie von Prionerkrankungen
US6214565B1 (en) * 1998-10-09 2001-04-10 The Regents Of The University Of California Assay for disease related conformation of a protein and isolating same
GB2371049B (en) * 1998-11-04 2003-06-04 Imp College Innovations Ltd Methods of making antibodies against ß-forms of prion proteins and their uses
GB2362385B (en) * 1998-11-04 2002-06-19 Imp College Innovations Ltd Non-aggregated ß-forms of prion proteins
GB2348203B (en) 1998-11-04 2002-06-19 Imp College Innovations Ltd Solube beta-forms of prion proteins, methods of preparation and use
FI982480A0 (fi) * 1998-11-17 1998-11-17 Wallac Oy Immunomääritys nisäkkäiden tarttuvan spongiomuotoisen aivotaudin määrittämiseksi
FI982481A0 (fi) * 1998-11-17 1998-11-17 Wallac Oy Immunomääritys nautaeläinten tarttuvan spongiomuotoisen aivotaudin määrittämiseksi
JP5122705B2 (ja) 1999-01-25 2013-01-16 ミナーヴァ・バイオテクノロジーズ・コーポレーション 神経変性疾患における異常型タンパク質凝集の迅速かつ高感度の検出
GB2346971B (en) * 1999-02-19 2004-07-21 Audrey Ann Coop Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins
DE19918141A1 (de) * 1999-04-21 2000-10-26 Boehringer Ingelheim Vetmed Verfahren zur Diagnose von übertragbaren Spongiformen Enzephalopathien
US7041807B1 (en) 1999-06-23 2006-05-09 Caprion Pharmaceuticals, Inc. Antibodies to a YYX epitope of a mammalian prion protein
ES2278617T3 (es) * 1999-06-23 2007-08-16 Idexx Laboratories Inc Peptidos de proteinas de prion y sus usos.
BR0012765A (pt) * 1999-07-27 2002-04-02 Imp College Innovations Ltd Peptìdeo, métodos de fabricar um anticorpo, de fabricar um agente de ligação capaz de ligar-se a uma forma celular de uma proteìna de prion, de remover uma forma celular de uma proteìna de prion de uma amostra, e de usar um anticorpo e/ou agente de ligação, anticorpo, agente de ligação, uso de um anticorpo ou agente de ligação, kit, e , sequência de peptìdeo de uma forma celular de uma proteìna de prion
JP2003514773A (ja) * 1999-09-28 2003-04-22 ウニヴェルジテート チューリッヒ 血清及び血漿中のプリオン結合活性を有する因子並びに伝染性海綿状脳障害を検出するための薬剤
FR2801106B1 (fr) * 1999-11-12 2007-10-05 Commissariat Energie Atomique Procede de diagnostic d'une esst provoquee par une souche d'atnc dans un echantillon biologique et son utilisation dans le diagnostic differentiel des differentes souches d'atnc
JP2003517313A (ja) 1999-12-15 2003-05-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア コンフォメーションおよびトポロジータンパク質の調節
DE60129674T2 (de) 2000-03-10 2008-06-05 Université De Genève Verfahren zur diagnose von transmissiblen spongiformen encephalopathien
GB2360089A (en) * 2000-03-10 2001-09-12 Univ Geneve Diagnostic assay for transmisible spongiform encephalopathies
FR2808278A1 (fr) * 2000-04-28 2001-11-02 Inst Nat Sante Rech Med Proteines a prions et leurs utilisations
DK1158003T4 (da) † 2000-05-23 2013-04-08 Blood Transfusion Ct Of Slovenia Antistoffer, som er i stand til selektivt at detektere prion PrP Sc-isoformer
US7098317B1 (en) * 2000-05-23 2006-08-29 Blood Transfusion Center Of Slovenia Antibodies capable to selectively detect prion PrPSc isoforms
IL141950A0 (en) * 2000-10-22 2002-03-10 Hadasit Med Res Service Diagnosis of prion diseases
NZ515982A (en) * 2000-12-08 2003-09-26 Fujirebio Kk Method and monoclonal antibodies for differentiation between abnormal and normal prions
US7303907B2 (en) 2001-01-08 2007-12-04 Health Protection Agency Degradation and detection of TSE infectivity
AU2002241909A1 (en) * 2001-01-19 2002-07-30 Baxter Healthcare S.A. Method of detecting prp protein and kits therefor
IES20010042A2 (en) * 2001-01-19 2002-12-11 Enfer Technology Ltd Test for transmissible spongiform encephalopathies
DE10104480A1 (de) * 2001-01-31 2002-08-14 November Ag Molekulare Medizin Verfahren, Verwendung und Kit zum Auffinden von Wirkstoffen gegen mit spezifischen Proteinen assoziierte Krankheiten
DE10106835A1 (de) * 2001-02-14 2002-09-05 Basf Lynx Bioscience Ag Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen
DE10120562C2 (de) * 2001-04-26 2003-04-10 Horst Messer Verfahren zur Diagnose von übertragbaren spongiformen Enzephalopathien
DE60217107T2 (de) * 2001-06-20 2007-08-23 Ramot At Tel Aviv University Ltd. Mehrantigenisches peptid enthaltend mehrere kopien eines epitopes von einem ablagerungsformenden polypeptid und dessen verwendung
DE10143647A1 (de) * 2001-09-05 2003-03-27 Prionics Ag Zuerich DNA-Sequenzen codierend für variable Bereiche von Antikörpern, die an das Prion-Protein (PrP) binden sowie PrP-bindende Polypeptide
AU2002349311B2 (en) * 2001-09-25 2007-11-08 Prionics Ag Test strips for the detection of prion proteins
US7045297B2 (en) 2001-11-14 2006-05-16 Prion Developmental Laboratories, Inc. Rapid prion-detection assay
US20030092199A1 (en) * 2001-11-14 2003-05-15 Kiamars Hajizadeh Prion-detection business methods
US20030092090A1 (en) * 2001-11-14 2003-05-15 Kiamars Hajizadeh Rapid prion-detection device, system, and test kit
EP1312617A1 (de) 2001-11-14 2003-05-21 ATOFINA Research Schlagzähes Polypropen
US20060228696A1 (en) * 2002-06-27 2006-10-12 Robert Rohwer Methods for detecting and inactivating a prion
EP1382971A1 (de) * 2002-07-17 2004-01-21 Pepscan Systems B.V. Nachweis von Prion Erkrankung
US20040072236A1 (en) 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
AU2002352042A1 (en) * 2002-11-18 2004-06-15 Prionics Ag Method for the detection of prpsc
GB0227886D0 (en) * 2002-11-29 2003-01-08 Medical Res Council Prion inhibition
AU2003266801B2 (en) * 2002-12-19 2010-02-25 Ortho-Clinical Diagnostics, Inc Detection and diagnosis of transmissable spongiform encephalopathies
US7399603B2 (en) 2002-12-19 2008-07-15 Ortho-Clinical Diagnostics, Inc. Antibodies for discrimination of prions
FR2849204B1 (fr) * 2002-12-20 2005-02-11 Afssa Procede de detection de la prpsc utilisant un antibiotique d de la famille des aminoglycosides pour l'elimination et la detection de la prpsc dans des echantillons biologiques
EP1445615A1 (de) * 2003-02-10 2004-08-11 Ortho-Clinical Diagnostics, Inc. Methode zur unterscheidung zwischen infektiösen und nicht-infektiösen prionen
EP1457500A1 (de) * 2003-03-14 2004-09-15 University of Zurich Lösliche Prionen-Hybrid-Proteine und deren Verwendung zur Diagnose, Behandlung und Prevention von transmissibler spongiformer Encephalopathie
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
ES2398394T3 (es) 2003-08-13 2013-03-15 Novartis Vaccines And Diagnostics, Inc. Reactivos peptídicos específicos de prión
AU2004266324B8 (en) * 2003-08-20 2011-04-28 Promis Neurosciences Inc. Epitope protection assay and method for detecting protein conformations
US20060199194A1 (en) * 2003-11-10 2006-09-07 Q-Rna, Inc. Methods of detection using immuno-Q-Amp technology
US20050214805A1 (en) * 2003-11-10 2005-09-29 Q-Rna, Inc. Methods of detection employing immuno-Q-Amp technology
EP1596199A1 (de) * 2004-05-14 2005-11-16 Prionics AG Verfahren zum Nachweis von pathogenen Prionenproteinen.
AU2005209592B2 (en) 2004-09-30 2012-07-12 Ortho-Clinical Diagnostics, Inc. Peptides for discrimination of prions
US20090130774A1 (en) * 2005-01-13 2009-05-21 David Peretz Elisa assays using prion-specific peptide reagents
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
WO2006076497A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Osplation of pathogenic prions
GB0501564D0 (en) * 2005-01-25 2005-03-02 Univ Cambridge Tech Test for prion disease
WO2006102099A2 (en) * 2005-03-18 2006-09-28 The Regents Of The University Of California ANTIBODIES SPECIFIC FOR HUMAN AND BOVINE PrP
RU2281510C1 (ru) * 2005-03-23 2006-08-10 Общество С Ограниченной Ответственностью "Биохарт" АНТИТЕЛА, СПЕЦИФИЧЕСКИ РЕАГИРУЮЩИЕ С ПРИОННЫМ ПРОТЕИНОМ PrP ИЛИ ЕГО ФРАГМЕНТОМ, И ИХ ПРИМЕНЕНИЕ
US20070015211A1 (en) * 2005-06-22 2007-01-18 Prosetta Corporation Conformer-specific antibodies and method of use, thereof
WO2007030804A1 (en) * 2005-09-09 2007-03-15 Novartis Ag Prion-specific peptoid reagents
US7794692B2 (en) * 2005-12-02 2010-09-14 Amorfix Life Sciences Ltd. Methods and compositions for detecting amyotrophic lateral sclerosis
US7887803B2 (en) 2005-12-02 2011-02-15 Amorfix Life Sciences Methods and compositions to treat misfolded-SOD1 mediated diseases
EP2514824A3 (de) 2006-03-03 2013-01-23 Amorfix Life Sciences Ltd. Verfahren und Zusammensetzungen zum Behandeln und Erkennen von missgefaltetem SOD 1-herbeigeführte Erkrankungen
JP5164971B2 (ja) * 2006-04-21 2013-03-21 ピープルバイオ,アイ エヌ シー 三次元的相互作用を用いてマルチマー形成ポリペプチドのモノマーからマルチマーを分別検出する方法
US8492097B2 (en) * 2006-04-24 2013-07-23 Diagnostic Hybrids, Inc. Compositions and methods for human metapneumovirus monoclonal antibodies
WO2008029965A1 (en) * 2006-09-08 2008-03-13 Peoplebio, Inc. Simultaneous reaction assay for differentially detecting multimeric form
US8013122B2 (en) 2006-12-20 2011-09-06 Kieu Hoang Method of purifying apolipoprotein A-1
JP2011520108A (ja) * 2008-04-30 2011-07-14 ノバルティス アーゲー 病原性配座異性体についてのアッセイ
BRPI1011404B1 (pt) * 2009-05-05 2022-05-03 Amgen Inc Polipeptídeos mutantes fgf21, polipeptídeo de fusão, multímero, composição farmacêutica, ácido nucleico isolado, vetor e célula hospedeira
US8828986B2 (en) 2011-04-20 2014-09-09 Prosetta Antiviral Inc. Antiviral compounds
US8785434B2 (en) 2010-04-30 2014-07-22 Prosetta Antiviral Inc. Antiviral compounds
WO2012125983A1 (en) 2011-03-17 2012-09-20 Prosetta Antiviral Inc. Antiviral treatments
US20120301904A1 (en) 2011-04-26 2012-11-29 Prosetta Antiviral, Inc Multiprotein assemblies
CN103044546B (zh) * 2011-11-24 2015-09-30 上海转基因研究中心 一种朊蛋白抗体及其制备方法和应用
CN102558349B (zh) * 2012-01-12 2013-12-11 吉林大学 一种识别天然结构梅花鹿朊蛋白的单克隆抗体及制备方法
CN102565410B (zh) * 2012-01-12 2014-08-06 吉林大学 一种梅花鹿朊蛋白免疫学检测方法
CA2891291A1 (en) 2012-11-12 2014-05-15 Moontunes, Inc. Systems and methods for communicating a live event to users using the internet
FR2998373B1 (fr) 2012-11-20 2015-01-09 Franklab Sas Procede de mesure de l'aptitude d'une formulation a inactiver un atnc.
WO2016149537A1 (en) 2015-03-17 2016-09-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bank vole prion protein as a broad-spectrum substrate for rt-quic-based detection and discrimination of prion strains
JP6716799B1 (ja) * 2020-02-07 2020-07-01 三菱日立パワーシステムズ株式会社 温度計保護筒、温度計測器具及び蒸気配管構造物並びに温度計保護筒の設置方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011155A1 (en) * 1991-12-03 1993-06-10 Proteus Molecular Design Limited Fragments of prion proteins
WO1993023432A1 (en) * 1992-05-15 1993-11-25 New York University Soluble prion polypeptides, and methods for detecting and purifying thereof
EP1416280A3 (de) * 1995-09-14 2005-08-10 The Regents of the University of California Antikörper spezifisch für natives PrPsc

Also Published As

Publication number Publication date
EP2172486A2 (de) 2010-04-07
CA2280791C (en) 2011-06-21
NZ336656A (en) 2002-05-31
US7259246B2 (en) 2007-08-21
DE69841102D1 (de) 2009-10-08
CA2280791A1 (en) 1998-08-27
US6765088B1 (en) 2004-07-20
AU6498698A (en) 1998-09-09
WO1998037210A1 (en) 1998-08-27
EP2172486B1 (de) 2014-11-05
US20060025575A1 (en) 2006-02-02
EP1007700A1 (de) 2000-06-14
EP1007700B1 (de) 2009-08-26
AU742838B2 (en) 2002-01-10
EP0861900A1 (de) 1998-09-02
EP2172486A3 (de) 2012-02-29

Similar Documents

Publication Publication Date Title
DE69841102D1 (de) Monoklonaler antikörper gegen ein prion protein und dessen verwendung zum nachweis von prionen
NL300335I2 (nl) Menselijke monoklonale antilichamen tegen epidermale groeifactorreceptor
AU2152299A (en) Multivalent antigen-binding proteins
DE69637930D1 (de) Für rsv f-proteine spezifische, menschliche, monoklonale antikörper mit hoher affinität
PL1625163T3 (pl) Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43
NO20092369L (no) Polypeptid som utgjor et celleoverflatemolekyl, polypeptidfragment, gen, vektor, transformant, fusjonspolypeptid, homodimert molekyl, farmasoytisk preparat, antistoff eller del av dette, hybridom og transgen mus
ZA200800555B (en) IL-1² binding antibodies and fragments thereof
DE69829891D1 (de) Anti-VEGF Antikörper
EP0330506A3 (de) VLA-Proteine
YU45501A (sh) Humana monoklonalna antitela za ctla-4
ATE372382T1 (de) Ein faktor viii-polypeptid mit faktor viii:c- aktivität
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
NO20052202D0 (no) Kjemokinreseptor 88C og dens antistoffer
AU6943800A (en) Antibodies specific for fullerenes
ATE250128T1 (de) Treponema palladium fusions-antigen, nachweis für anti-treponema palladium antikörpern mit diesen fusions-antigenen
DE69835047D1 (de) Schaumproteine, monoklonale Antikörper dagegen, und deren Verwendungen
ATE143669T1 (de) Hcg-peptide zur verwendung in antikörper- reinigungsverfahren
DE502005004379D1 (de) Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung
BR9606557A (pt) Anticorpo monoclonal hibridoma polipeptídeo purificado e isolado polinucleotídeo purificado e isolado DNA célula hospedeira e método para produzir o polipeptídeo
WO2003061561A8 (en) Epsilon immunoglobulin chain derived peptides for induction of anti-ige antibodies
ATE405646T1 (de) Ein verfahren zum auffinden vom prostatakrebs
PT93394A (pt) Processo para a preparacao de celulas de hibridonas produzindo anticorpos ligaveis a moleculas de adesao intercelular
EP1026173A4 (de) Antihumane thymidylat-synthasemonoklonale antikörper und hybridomazellen zu deren herstellung
ATE239754T1 (de) An nukleinsäure gebundenes polypeptid, verfahren zur herstellung eines an nukleinsäure gebundenen polypeptides und immunoassay, in dem dieses polypeptid verwendung findet

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties